Sleep Apnea Devices Market Is Forecasted to Value Over $ 6 Billion by 2026 End

  • 07 Aug 2019

Global Sleep Apnea Devices Market is estimated to value over USD 6 billion by 2026 end and is expected to register a CAGR of over 10% during the forecast period from 2019 to 2026.

With advancements in medical sciences and technology, life expectancy has increased and thus has led to the rise of the geriatric population. This is expected to drive the prevalence of Obstructive Sleep Apnea (OSA) and sleep apnea devices play a key role here which is anticipated to fuel the market growth. Heightened consciousness about sleep disorders, their remedies and precautionary measures, precise and early disease diagnosis, patient adherence, and rise in financial dispensability to allow healthcare expenditure is forecasted to accelerate the revenue growth.

With the rise in the geriatric population, the health complications also increase gradually thus demanding more healthcare facilities and aid. A decrease in the dimension of the upper airway lumen due to the rising age can cause OSA, thus fueling the market’s demand worldwide. According to the United Nations (UN), the global geriatric community was nearly 962 million and it is anticipated to foster and grow twice as much by 2050.

Sleep disorders are becoming increasingly prevalent as a disease, and the high frequency of this disease requires efficient diagnosis and treatment and these are some administrators elevating revenue growth of the sleep apnea devices market. The influx of technological improvements provisioning patient protection and convenience is anticipated to enhance treatment adherence, particularly in mature markets such as North America. One of the most developed markets, North America, is growing unboundedly owing to great product acceptance along with government initiatives directed at restraining healthcare expenditure. The shift from taxed healthcare services to patient value and care along with the availability of reimbursement are some of the factors driving regional growth.

Improper diagnosis along with the delay in the examination can lead to serious health risks. Prolonged sleep apnea doubles the mounting risk of additional complications such as hypertension, cardiac diseases, diabetes, and mental disorders which in turn raises the overall healthcare cost burden on the economy. Building awareness regarding the continued consequences of sleep apnea is foreseen to boost revenue growth over the forecast period.

The therapeutic devices segment constituted the largest and highest portion of the market during the forecast period and is projected to continue expansion and record growth at the highest CAGR. The important factors aiding this growth are the expanding pool of undiagnosed sleep apnea patients across the globe and the improving reimbursement of patient adherence for these devices. The preference of patients leads to increased global acceptance of oral appliances considering the high rate of non-compliance with PAP devices.

The sleep laboratories & hospital segment valued for the most substantial share of the market, while home care settings/individuals segment is predicted to develop at the highest CAGR during the forecast period. This tremendous expansion is expected to be motivated by administrators such as the soaring inclination for home sleep testing by both patients and private insurance companies, along with the favorable reimbursement scenario for home sleep testing.  

Geographically, North America is forecasted to acquire the highest market share. This geographical advancement is fundamentally encouraged by the growing incidence of sleep disorders and heightened government and non-governmental initiatives to raise awareness of diagnosis and health. Several governments administer programs to raise awareness of healthy sleeping habits for individuals and physicians. The main players in the regional market invest an enormous amount of capital to create sleep apnea equipment that is technologically efficient, efficient and simple to use, thus promoting the market worldwide.

Recent Developments

The global market is always booming with new innovations. Brimming with the latest technological advancements integrated to enhance patient experience and provide seamless treatment encourage the global market and its growth. ResMed (US) introduced the AirFit N30i, the first top-of-head-connected nasal CPAP mask, across North America with the latest invented nasal cradle cushion that rests just under the wearer’s nose, providing extra comfort.

Koninklijke Philips (Netherlands) launched its Dream Family solution which constitutes a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app. All of these innovations help boost the market, propagate the market as well as increase the viability of patient’s adopting it.

Market Segmentation

By Type

  • Therapeutic Devices
    • Positive Airway Pressure Devices
    • Automatic Positive Airway Pressure Devices
    • Continuous Positive Airway Pressure Devices
    • Bilevel Positive Airway Pressure Devices
  • Facial Interfaces
  • Masks
    • Full-Face Masks
    • Nasal Pillow Masks
    • Nasal Masks
  • Cushions
  • Accessories
  • Oral Appliances
    • Mandibular Advancement Devices
    • Tongue-Retaining Devices
  • Adaptive Servo-Ventilators
  • Other Therapeutic Devices
  • Diagnostic Devices
    • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
    • Home Sleep Testing Devices
  • Oximeters
    • Fingertip Oximeters
    • Handheld Oximeters
    • Wrist-Worn Oximeters
    • Tabletop Oximeters
  • Actigraphy Systems
  • Sleep Screening Devices

 By End-User

  •  Sleep Laboratories & Hospitals
  •  Home Care Settings/Individuals

By Region

  •  Europe
  •  North America
  •  APAC
  •  Latin America
  •  Rest of World

Competitive Landscape:

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants 

Major firms in the market are BMC Medical Co. Ltd; Braebon Medical Corporation; Nihon Kohden; Cadwell Laboratories; ResMed; ImThera Medical Inc.; Invacare Corporation; Fisher & Paykel Healthcare Limited; GE Healthcare; Curative Medical Inc.; Curative Medical Inc.; Philips Respironics; and Compumedics Limited.

FutureWise Takeaways:

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data points affecting market growth

Objectives of the Study:

  • To provide an exhaustive analysis on the global sleep apnea market by product type, by end-user and by region
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
  •  To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact